FDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decisionPfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal Share XFDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decisionhttps://pharmaphorum.com/news/fda-clears-pfizers-prevnar-20-for-adults-as-merck-rival-nears-decision/
Adult data back Merck & Co’s challenger to Pfizer’s blockbuster Prevnar 13Merck & Co has built more momentum behind its attempt to depose Pfizer’s blockbuster pneumococcal conjugate vaccine Prevnar Share XAdult data back Merck & Co’s challenger to Pfizer’s blockbuster Prevnar 13https://pharmaphorum.com/news/adult-data-back-mercks-challenger-to-pfizers-blockbuster-prevnar-13/
